Recombinant activated factor VII to control bleeding in cardiovascular surgery: Need of efficacy and safety validation;Facteur VII recombinant et activé pour le contrôle du saignement en chirurgie cardiovasculaire: Valider l'efficacité et la sécurité d'emploi

Annales Francaises d'Anesthesie et de Reanimation

Volumn 25, Issue 1, 2006, Pages 2-5

  Blanloeil, Y ^a   Rigal, J C ^a   Bastien, O ^b   Carteau, J P ^c   Toussaint Hacquard, M ^c   Lecompte, T ^c  

^a CHU de Nantes   (France)

^b LOUIS PRADEL HOSPITAL   (France)

^c CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; RECOMBINANT FACTOR VII; UNCLASSIFIED DRUG;

BLEEDING; CARDIOVASCULAR SURGERY; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; VALIDATION STUDY;

CARDIAC SURGICAL PROCEDURES; CLINICAL TRIALS; FACTOR VII; HEMORRHAGE; HUMANS; INTRAOPERATIVE COMPLICATIONS; RECOMBINANT PROTEINS; THROMBOSIS;

EID: 31344470985     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2005.09.005     Document Type: Editorial

References (61)

1. C.R. Hay, C. Negrier, and C.A. Ludlam The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicenter study Thromb. Haemost. 78 1997 1463 1467
2. M. Lynn, I. Jeroukhimov, Y. Klein, and U. Martinowitz Updates in the management of severe coagulopathy in trauma patients Intensive Care Med. 28 2002 S241 S257
3. M. Grounds Recombinant factor VIIa and its use in severe bleeding in surgery and trauma: a review Blood Rev. 17 2003 S11 S21
4. R.P. Dutton, M. McCunn, M. Hyder, M. D'Angelo, J. O'Connor, and J.R. Hess Factor VIIa for correction of traumatic coagulopathy J. Trauma 57 2004 709 719
5. M. Laffan, N.M. O'Connel, D.J. Perry, A.J. Hodgson, D. O'Shaughnessy, and O.P. Smith Analysis and results of the recombinant factor VIIa extended-use registry Blood Coagul. Fibrinolysis 14 suppl1 2003 S35 S38
6. M. Levi Safety of recombinant factor VIIa TATM 2003 515 519
7. A. Mayo, M. Misgav, Y. Kluger, R. Geenberg, D. Pauzner, and J. Klausner Recombinant activated factor VII (Novoseven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding Vox Sang. 87 2004 34 40
8. H.R. Roberts, D.M. Monroe, and G.C. White The use of recombinant factor VIIa in the treatment of bleeding disorders Blood 104 2004 3858 3864
9. T. Abshire, and G. Kenet Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors J. Thromb. Haemost. 2 2004 899 909
10. M.E. Carr, and E.J. Martin Recombinant factor VIIa: clinical applications for intravenous hemostatic agent with broad-spectrum potential Expert Review Cardiovasc. Therapy 2 2004 661 674
11. J.F. Barletta, C.L. Ahrens, J.G. Tyburski, and R.F. Wilson A review of recombinant factor VII for refractory bleeding in nonhemophilic trauma patients J. Trauma 58 2005 646 651
12. M. Franchini, M. Zannanello, and D. Veneri Recombinant factor VIIa: an update on its clinical use Thromb. Haemost. 93 2005 1027 1035
13. M. Levi, M. Peters, and H.R. Büller Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review Crit. Care Med. 33 2005 883 890
14. B.E. Ickx RFVIIa (Novoseven): the new panacea? Acta Anaesthesiol. Belg. 54 2003 333 335
15. D.R. Spahn, and M. Makris Is recombinant FVIIa the magic bullet in the treatment of major bleeding? Br. J. Anaesth. 94 2005 553 555
16. R.J. Parker Recombinant activated factor VII: panacea or passing fad? Pediatr. Crit. Care Med. 6 2005 379 380
17. H.R. Roberts Recombinant factor VIIa: how safe is the stuff? Can. J. Anaesth. 52 2005 8 11
18. G. Despotis, M. Avidan, and D.M. Lublin Off-label use of recombinant factor VIIa concentrates after cardiac surgery Ann. Thorac. Surg. 80 2005 3 5
19. G. Kenet, R. Walden, A. Eldad, and U. Marinovitz Treatment of traumatic bleeding with recombinant factor VIIa Lancet 354 1999 1879
20. A. Brice, U. Hilbert, S. Roger-Christoph, H. Fernandez, A.S. Dumenil, and A. Descorps-Decl̀re Int́r̂t du facteur VII activ́ recombinant dans l'h́morragie de la d́livrance śv̀re ŕfractaire ̀ la prise en charge conservatrice conventionnelle Ann. Fr. Anesth. Ŕanim. 23 2004 1084 1088
21. L. Tual, M. Kirsch, J.M. Servant, L. Drouet, and G. Dhonneur Administration de facteur VII activ́ recombinant chez une patiente porteuse d'une assistance ḿcanique ventriculaire gauche Ann. Fr. Anesth. Ŕanim. 2005 (dans ce nuḿro)
22. M. Zietkiewicz, M. Garlicki, and J. Domalga Successful use of activated recombinant factor VIIa to control bleeding abnormalities in a patient with a left ventricular assist device J. Thorac. Cardiovasc. Surg. 123 2002 384 385
23. E.V. Potapov, M. Pasic, and M. Bauer Activated recombinant factor VIIa for control of diffuse bleeding after implantation of ventricular assist device Ann. Thorac. Surg. 74 2002 2182 2183
24. J.D. Flynn, P.C. Camp, M.S. Jahania, C. Ramiah, and W.S. Akers Successful treatment of refractory bleeding after bridging from acute to chronic left ventricular assist device support with recombinant activated factor VII ASAIO 50 2004 519 521
25. A. Kogan, M. Berman, Y. Kassif, E. Raanani, A. Stamler, and T. Ben Gal Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation J. Heart Lung Transplant. 24 2005 347 349
26. J.D. Bui, G.D. Despotis, and E.P. Trulock Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII J. Thorac. Cardiovasc. Surg. 124 2002 852 854
27. A. Verijckt, F. Proulx, S. Morneau, and S. Vobecky Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation J. Thorac. Cardiovasc. Surg. 127 2004 1812 1813
28. B. Wittenstein, C. Ng, H. Ran, and A. Goldman Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery Pediatr. Crit. Care Med. 6 2005 473 476
29. M. Manso, F. Rodriguez Amuedo, R. Aragones Manzanero, M.C. Ferriz, P. Munoz, and C. Calvo Macias Effectiveness of activated factor VII in postoperative bleeding after cardiac surgery with extracorporeal membrane oxygenation Ann. Pediatr. (Barc.) 62 2005 467 470
30. J. Lopez-Herce Cid, G. Arriola Pereda, J.L. Zunzunegui Martinez, and K.B. Brandstrup Azuero Effectiveness of activated factor VII in postoperative bleeding after cardiac surgery with extracorporeal membrane oxygenation Ann. Pediatr. (Barc.) 62 2005 471 474
31. M. Al Douri, T. Shafi, D. Al Khudairi, E. Al Bokhari, N. Akinwak, and M. Osman Musa Effect of the administration of recombinant activated factor VII in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery Blood Coagul. Fibrinolysis 11 suppl 1 2000 S121 S127
32. H.G. Hendriks, J.M. Van der Maaten, and J. De Wolf An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII Anesth. Analg. 93 2001 287 289
33. C. Von Heymann, H. Hotz, and W. Konertz Successful treatment of refractory bleedings with recombinant factor VIIa after redocoronary artery bypass graft surgery Cardiothorac. Vasc Anesth 16 2002 615 616
34. M. Kastrup, C. Von Heymann, and H. Hotz Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta Ann. Thorac. Surg. 74 2002 910 912
35. K. Tanaka, A. Waly, and W. Cooper Treatment of excessive bleeding in Jehovah's witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven®) Anesthesiology 98 2003 1513 1515
36. V.N. Naik, C.D. Mazer, and D.A. Latter Successful treatment using recombinant factor VIIa for severe bleeding post-cardiopulmonary bypass Can. J. Anesth. 50 2003 599 602
37. T. Vanek, Z. Straka, J. Hrabak, M. Jares, P.J. Brucek, and J. Votava Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding Jpn. Heart J. 45 2004 855 860
38. A. Kogan, M. Berman, M. Stein, B.A. Vidne, and E. Raanani Recombinant factor VIIa use in cardiac surgery - expanding the arsenal therapy for intractable bleeding? J. Cardiovasc. Surg. (Turino) 45 2004 569 571
39. T. Haas, P. Innerhofer, G. Kühbacher, and D. Fries Successful reversal of deleterious coagulopathy by recombinant factor VIIA Anesth. Analg. 100 2005 54 58
40. M.E. Halkos, J.H. Levy, E. Chen, S. Reddy, O.M. Lattouf, and R.A. Guyton Early experience with activated recombinant factor VII for intractable hemorrhage following cardiovascular surgery Ann. Thorac. Surg. 67 2005 1 11
41. M. Hyllner, E. Houltz, and A. Jeppsson Recombinant factor VII in the management of life-threatening bleeding in cardiac surgery Eur. J. Cardiothorac. Surg. 28 2005 254 258
42. L. Leibovitch, G. Kenet, and K. Mazor Recombinant activated factor VII for life threatening pulmonary haemorrhage after pediatric cardiac surgery Pediatr. Crit. Care Med. 4 2003 444 446
43. J.D. Tobias, J.W. Berkenbosch, and P. Russo Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant Pediatr. Crit. Care Med. 4 2003 49 51
44. M. Pychynska-Pokorska, J.J. Moll, W. Krajewski, and P. Jarosik The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass Pediatr. Crit. Care Med. 5 2004 246 250
45. J.R. Egan, A. Lammi, D.N. Schell, J. Hillis, and G.R. Nunn Recombinant activated factor VII in paediatric cardiac surgery Intensive Care Med. 30 2004 682 685
46. Y. Razon, E. Erez, B. Vidne, E. Birk, J. Katz, and H. Tamari Recombinant factor VIIa as a hemostatic agent after surgery for congenital heart disease Pediatr. Anaesth. 15 2005 235 240
47. A. Liem, D.H. Biesma, and S. Ernst Recombinant activated factor VII for false aneurysm in patients with normal haemostasis mechanisms Thromb. Haemost. 82 1999 150 151
48. L. Lhotel, G. Godet, J.F. Baron, M. Gourdin, M.H. Fĺron, and P. Coriat Facteur VII activ́ et saignement de la chirurgie des ańvrismes thoracoabdominaux:? Évaluation ̀ travers un protocole compassionnel Ann. Fr. Anesth. Reanim. 21 2002 R347
49. C.M. Wahlgren, and J. Swedenborg The use of recombinant activated factor VII to control bleeding during repair of a suprarenal aortic aneurysm Eur. J. Vasc. Endovsc. Surg. 16 2003 221 222
50. G. Stratman, I.A. Russell, Merrick, and SH Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair Ann. Thorac. Surg. 76 2003 2094 2097
51. R.J. Pugh, R. Westone, V.J. Martlew, and G. Marx Use of recombinant factor VIIa for major haemorrhage Eur. J. Anaesthesiol. 22 2005 548 550
52. Aggarwal A, Alcorn K. Recombinant activated factor VIIa as salvage treatment in the management of perioperative intractable bleeding in cardiac surgery patients. J. Thrombosis Haemost. 2003; Suppl 1: P0602.
53. C. Kessler, D. Szurlej, and C. Von Heymann Management of refractory postoperative cardiac bleeding with recombinant factro VIIa: cases reported to the hemostasis.com registry J. Thromb. Haemost. Suppl 1 2003 1131
54. C. Von Heymann, M. Kastrup, U. Redlich, W. Kox, and C. Speis Experiences with recombinant activated factor VIIa for refractory bleeding after cardiac surgery. A retrospective analysis Anesthesiology 99 2003 A442
55. K. Karkouti, W.S. Beattie, D.N. Wijeysundera, T.M. Yau, S.A. McCluskey, and M. Ghannam Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis Transfusion 45 2005 26 34
56. P. Raivio, R. Suojaranta-Ylinen, and A.H. Kuitunen Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery Ann. Thorac. Surg. 80 2005 66 71
57. W. Dietrich, and M. Spannagl Caveat against the use of activated recombinant factor VII for untractable bleeding in cardiac surgery Anesth. Analg. 94 2002 1369 1371
58. M. Fattorutto, S. Tourreau-Pham, E. Mazoyer, P. Bonnin, M. Raphael, and F. Morin Recombinant activated factor VII decreases bleeding without increasing arterial thrombosis in rabbits Can. J. Anaesth. 51 2004 672 679
59. U. Martinovitz, M. Michaelson the Israeli Multidisciplinary rFVIIa Task Force Guidelines for the use of recombinant activated factor VIIa in uncontrolled bleeding: a report J. Thromb. Haemost. 3 2005 640 648
60. G. Price, J. Kaplan, and G. Skowronski Use of recombinant factor VIIa to treat life-threatening non-surgical bleeding in a post-partum patient Br. J. Anaesth. 93 2004 298 300
61. J. Ahonen, and R. Jokela Recombinant factor VIIa for life-threatening post-partum haemorrhage Br. J. Anaesth. 94 2005 592 595